• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25 filed by Zealand Pharma A/S

    9/20/22 4:06:54 PM ET
    $ZEAL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ZEAL alert in real time by email
    25 1 tm2226307d1_25.htm FORM 25

     

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION 

    Washington, D.C. 20549

     

    FORM 25

     

    NOTIFICATION OF REMOVAL FROM LISTING AND/OR 

    REGISTRATION UNDER SECTION 12(b) OF THE 

    SECURITIES EXCHANGE ACT OF 1934

     

    Commission File Number 001-38178

     

    Zealand Pharma A/S 

    The Nasdaq Global Select Market 

    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

     

    Sydmarken 11 

    2860 Søborg (Copenhagen)
    Denmark
     

    Tel: +45 88 77 36 00 

    (Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices))

     

    American Depositary Shares, each representing one ordinary share, DKK 1 nominal value per share 

    (Description of class of securities)

     

    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

     

    ¨ 17 CFR 240.12d2-2(a)(1) 

     

    ¨ 17 CFR 240.12d2-2(a)(2) 

     

    ¨ 17 CFR 240.12d2-2(a)(3) 

     

    ¨ 17 CFR 240.12d2-2(a)(4) 

     

    ¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.

     

    x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

     

     

     

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Zealand Pharma A/S certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

     

      Zealand Pharma A/S
         
    Date: September 20, 2022 By: /s/ Lykke Rømer
        Lykke Rømer
        Interim Chief Financial Officer

     

     

    Get the next $ZEAL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZEAL

    DatePrice TargetRatingAnalyst
    3/5/2024Buy
    Berenberg
    8/8/2023Equal-Weight
    Morgan Stanley
    11/16/2022Overweight → Equal-Weight
    Morgan Stanley
    1/11/2022Hold → Buy
    Jefferies
    More analyst ratings

    $ZEAL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Berenberg initiated coverage on Zealand Pharma

      Berenberg initiated coverage of Zealand Pharma with a rating of Buy

      3/5/24 7:30:01 AM ET
      $ZEAL
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Morgan Stanley resumed coverage on Zealand Pharma

      Morgan Stanley resumed coverage of Zealand Pharma with a rating of Equal-Weight

      8/8/23 7:40:54 AM ET
      $ZEAL
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Zealand Pharma downgraded by Morgan Stanley

      Morgan Stanley downgraded Zealand Pharma from Overweight to Equal-Weight

      11/16/22 9:37:00 AM ET
      $ZEAL
      Biotechnology: Pharmaceutical Preparations
      Health Care